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We report the investigation of illness and infection with severe acute respiratory syndrome corona-
virus 2 (SARS-CoV-2) in a household cat in Belgium (1). 
The cat was a female domestic shorthair, ≈15 years of 
age, that had been adopted 2 years earlier. The owner 
considered the cat to have been healthy since adoption, 
although it had never been assessed by a veterinarian. 
In February 2020, the owner took part in a 7-day tour 
to a mountain resort in Lombardy, Italy. The day after 
returning home, March 2, the owner felt suddenly too 
short of breath to conduct normal activities. As a pre-
cautionary measure, the family doctor decided to take 
a deep oropharyngeal swab sample and asked the pa-
tient to remain at home until the test result was report-
ed. Over the next 10 days, the patient experienced a 
series of general, respiratory, and then digestive symp-
toms consistent with the clinical signs associated with 
coronavirus disease (COVID-19) (Figure). On March 6, 
the swab sample was declared positive for the SARS-
CoV-2 genome, and home quarantine was extended 
until the end of March.
During that time, the patient’s household cat 
was asymptomatic (Video 1, https://wwwnc.cdc.
gov/EID/article/26/12/20-2223-V1.htm). However, 
1 week later, the cat suddenly demonstrated clinical 
signs; the cat was found prostrated and vomiting in 
her litter, then showed pronounced lethargy, poor 
appetite to anorexia, vomiting, and diarrhea (Figure). 
Several days later, the clinical signs worsened. The cat 
demonstrated sneezing (Video 2, https://wwwnc.
cdc.gov/EID/article/26/12/20-2223-V2.htm; Video 
3, https://wwwnc.cdc.gov/EID/article/26/12/20-
2223-V3.htm); a harsh, productive cough sev-
eral times a day; episodes of paroxysmal reverse 
sneezing (Video 4 https://wwwnc.cdc.gov/EID/
article/26/12/20-2223-V4.htm; Video 5, https://ww-
wnc.cdc.gov/EID/article/26/12/20-2223-V5.htm); 
labored breathing with increased respiratory effort 
and frequency; and emaciation (Video 6, https://
wwwnc.cdc.gov/EID/article/26/12/20-2223-V6.
htm). The clinical impression at this time was that of 
a restrictive breathing pattern suggestive of substan-
tial involvement of parenchyma, pleura, or both. The 
cat’s condition then gradually improved; she became 
less lethargic, vomiting stopped, feces resumed nor-
mal consistency, episodes of cough became less fre-
quent, and appetite quickly improved. The cat recov-
ered completely within <2 weeks.
A series of laboratory analyses were then con-
ducted (Appendix, https://wwwnc.cdc.gov/EID/
article/26/12/20-2223-App1.pdf). The cat’s owner 
collected 26 swab samples according to instructions 
received by telephone; 16 samples contained varying 
amounts of the SARS-CoV-2 genome (Table). Overall, 
positive samples were detected March 11–24. The cat 
was examined by veterinarians at the time of blood 
sampling on day 22 after onset of first symptoms. 
Clinical examination of the cat was unremarkable at 
that time, and auscultation of the thorax revealed no 
abnormalities. Results of a complete blood count and 
a serum biochemistry panel were within reference 
ranges. Presence of serum IgG was first sought by 
Western blotting of mock-exposed and SARS-CoV-2–
exposed Vero E6 cells lysates. In convalescent-phase 
serum, 5 protein bands that were simultaneously ab-
sent from mock-exposed Vero E6 cell lysates were 
identified (Appendix Figure). Furthermore, the con-
valescent-phase serum was positive by double-epit-
ope sandwich ELISA and for 2 of the 3 antigens tested 
by double-epitope luciferase assay (Table; Appendix 
Table). Whereas serum samples from 30 control cats 
and 10 control humans were negative by virus neu-
tralization assay, the convalescent-phase serum sam-
ples from the cat and her owner were positive; end-
points were 1:512 for the cat and 1:128 for the human.
The cat at first showed general signs, then gastro-
intestinal signs, and finally respiratory signs, similar 
to those observed in humans. Subsequently examined 
samples from the cat revealed viral RNA persisting 
for about 10 days. With the exception of a vomitus 
fluid sample collected on March 13, the amounts of 
viral RNA were relatively low. For this reason, and 
In March 2020, a severe respiratory syndrome developed 
in a cat, 1 week after its owner received positive test re-
sults for severe acute respiratory syndrome coronavirus 
2. Viral RNA was detected in the cat’s nasopharyngeal 
swab samples and vomitus or feces; immunoglobulin 
against the virus was found in convalescent-phase se-
rum. Human-to-cat transmission is suspected.
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despite the simultaneous presence of a compatible 
clinical syndrome and a suggestive chronology of 
events, we cannot automatically rule out passive con-
tamination of the cat’s samples by its owner.
To confirm the hypothesis of a productive in-
fection of the cat, we conducted a series of serologic 
analyses by using 4 different testing approaches and 
targeting distinct viral protein targets. All procedures 
Figure. Timeline of disease course for human and cat with SARS-CoV-2 infection, by days from illness onset according to the cat 
owner, Belgium, February 22–March 25, 2020. NA, not available; ND, not determined; SARS-CoV-2, severe acute respiratory syndrome 
coronavirus 2.
 
Table. Severe acute respiratory syndrome coronavirus 2 genome loads measured by qRT-PCR in a series of consecutive swab 
samples from cat, Belgium, March 2020* 
Date 





-actin gene N gene actin gene N gene -actin gene N gene 
 11 NS NS  26.95 23.5  0.1  35.5 33.3  0.2 
 12 33.4 38.2  0.5  NS NS  32.9 34.8  0.0 
 13 37.8 37.9  0  ND 34.9  0.1  34.4 37,6  0,1 
 14 25.1 39.3  0.1  NS NS  30.7 35.1 0.1 
 15 35.9 35.7  0.1  NS NS  27.8 33.2  0.1 
 16 38.2 Negative  NS NS  26.0 35.1  0 
 17 27.1 38.2  0  NS NS  28.7 Negative 
 18 26.7 Negative  NS NS  36.1 37.9  0 
 19 NS NS  NS NS  27.9 39.0  0 
 20 NS NS  NS NS  30.1 Negative 
 21 NS NS  29.9 33.8  0.1  32.8 Negative 
 22 37.9 Negative  NS NS  31.7 Negative 
 23 NS NS  NS NS  33.8 Negative 
 25 NS NS  34.9 Negative  35.0 Negative 
*Numbers reported are defined as the number of cycles required for the real-time PCR assay fluorescent signal curve to intersect with 
a threshold line that exceeds background level (mean  SD). It is a relative measure of the concentration of the genomic target in the 
qRT-PCR reaction (the severe acute respiratory syndrome coronavirus 2 N gene or cat β-actin gene); values >40 are considered 
negative. All samples with qRT-PCR values <40 were analyzed further by a standard gel RT-PCR targeting the coding sequence of 
the virus spike protein gene followed by Sanger sequencing of the correctly sized amplicon retrieved (370 bp). Only samples positive 
for all 3 tests were defined as positive, which was the case for all samples with a value <40 for the N gene aggregated in this table. 
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converged toward the same result: the convalescent-
phase serum from the cat contained immunoglobu-
lins against SARS-CoV-2, which were absent from 
the serum from control cats. These antibodies target 
several distinct viral proteins, and they caused a total 
neutralizing effect up to a much higher dilution than 
those from the owner’s serum. This household cat 
was therefore productively infected with the SARS-
CoV-2 virus excreted by its owner, and the infection 
caused a nonfatal but nevertheless severe disease, 
mainly of the respiratory system (Videos 2–6).
Public health officials are still learning about 
SARS-CoV-2, but no current evidence indicates that 
pets play a role in spreading the virus. Therefore, tak-
ing measures against companion animals that may 
compromise their welfare is not justified.
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Naturally occurring human-to-animal trans-mission of severe acute respiratory syndrome 
(SARS) coronavirus was reported during 2003 when 
viral RNA was detected in oropharyngeal and rec-
tal swab specimens from healthy domestic cats in a 
housing estate at the center of a large SARS cluster 
in Hong Kong, China; infections were confirmed se-
rologically (1). Susceptibility of cats to infection with 
this virus and transmission between cats were dem-
onstrated experimentally (2). Pulmonary pathologic 
changes, similar to those for humans with SARS, 
developed in infected cats, but the cats remained as-
ymptomatic (2,3).
These findings informed the current precaution-
ary strategy of the Agriculture, Fisheries and Con-
servation Department of Hong Kong to quarantine 
mammalian pets from households with confirmed 
human coronavirus disease (COVID-19) or their 
close contacts (defined as a person who had face-
to-face contact for >15 min with a person who had 
confirmed SARS Coronavirus-2 [SARS-CoV-2] in-
fection) in a holding facility, when alternative care 
was unavailable. Pets are swabbed for SARS-CoV-2 
testing and confined until reverse transcription PCR 
(RT-PCR) results are negative on 2 consecutive oc-
We tested 50 cats from coronavirus disease households or 
close contacts in Hong Kong, China, for severe acute re-
spiratory syndrome coronavirus 2 RNA in respiratory and 
fecal samples. We found 6 cases of apparent human-to-
feline transmission involving healthy cats. Virus genomes 
sequenced from 1 cat and its owner were identical.
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